USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
QUANTUMBIO, INC.
Address:
200 INNOVATION PARK, STE 261
STATE COLLEGE, PA
Phone:
N/A
URL:
N/A
EIN:
412039683
DUNS:
172210572
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $424,920.00 4
SBIR Phase II $3,096,722.00 3
STTR Phase I $99,323.00 1
STTR Phase II $879,115.00 1

Award List:

In Silico Screening for Biothreat Countermeasures

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$69,353.00
Agency / Branch:
DOD / CBD
Principal Investigator:
Lance Westerhoff, Chief Software Engineer
Abstract:
The current state of the art of in silico drug discovery or computer aided drug discovery relies almost exclusively on molecular mechanics force fields, such as AMBER and CHARMM, and empirical potentials. It is well known that while these approaches are excellent for certain applications, they have… More

Enhancement and Deployment of the Quantum Mechanical NMR Pose Scoring Method

Award Year / Program / Phase:
2007 / STTR / Phase II
Award Amount:
$879,115.00
Agency:
HHS
Principal Investigator:
Research Institution:
N/A
RI Contact:
N/A
Abstract:
Not avaiable.

Deployment of Quantum Mechanical Pairwise Energy Decomposition for Drug Discovery

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$98,914.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The current state of the art of in silico drug discovery relies almost exclusively on molecular mechanics force fields, such as AMBER, and empirical potentials. It is well known that while these approaches are excellent for certain applications, they have thus… More

Deployment of Quantum Mechanical Pairwise Energy Decomposition for Drug Discovery

Award Year / Program / Phase:
2008 / SBIR / Phase II
Award Amount:
$769,214.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The current state of the art of in silico drug discovery relies almost exclusively on molecular mechanics force fields, such as AMBER, and empirical potentials. It is well known that while these approaches are excellent for certain applications, they have thus… More

Enhancement and Deployment of the Quantum Mechanical X-ray Refinement Model

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$108,741.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Combined Improving human health by enabling the development of drugs faster and cheaper is an important part of the NIH mission. This is partially achieved by introducing and constantly improving enabling technologies. One such technology is structure based drug… More

Enhancement and Deployment of the Quantum Mechanical X-ray Refinement Model

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$1,256,800.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

Research and Deployment of a quantum mechanical NMR tool for fragment based drug

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$147,912.00
Agency:
HHS
Principal Investigator:
Lance M. Westerhoff – 814-235-6908
Abstract:
DESCRIPTION (provided by applicant): Improving human health by enabling the development of drugs faster and cheaper is an important part of the NIH mission. This is partially achieved by introducing and constantly improving enabling technologies. One suchtechnology is structure based drug design.… More

Research and Deployment of a quantum mechanical NMR tool for fragment based drug

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$1,070,708.00
Agency:
HHS
Principal Investigator:
Lance M. Westerhoff – 814-235-6908
Abstract:
DESCRIPTION (provided by applicant): Improving human health by enabling the development of drugs faster and cheaper is an important part of the NIH mission. This is partially achieved by introducing and constantly improving enabling technologies. One suchtechnology is structure based drug design.… More